{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:15:56Z","timestamp":1787836556960,"version":"build-2784847793"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82122033"],"award-info":[{"award-number":["82122033"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92259304"],"award-info":[{"award-number":["92259304"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shaanxi Province Key Industry Innovation Chain","award":["S2024-YF-ZDCXL-ZDLSF-0064"],"award-info":[{"award-number":["S2024-YF-ZDCXL-ZDLSF-0064"]}]},{"name":"Xijing Hospital Medical Personnel Training Promotion Project","award":["XJZT24JC15"],"award-info":[{"award-number":["XJZT24JC15"]}]},{"name":"Xijing Hospital Medical Personnel Training Promotion Project","award":["XJZT24LZ03"],"award-info":[{"award-number":["XJZT24LZ03"]}]},{"name":"Xijing Hospital Medical Staff Technology Enhancement Program","award":["2024XJSY35"],"award-info":[{"award-number":["2024XJSY35"]}]},{"name":"Xijing Hospital Medical Staff Technology Enhancement Program","award":["2024XJSM04"],"award-info":[{"award-number":["2024XJSM04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s11307-025-02028-x","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T11:49:20Z","timestamp":1750765760000},"page":"540-549","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Diagnostic Value of [18F]-FDG and [68\u00a0Ga]-FAPI-04 PET\/MRI for Lymph Node Metastasis in Papillary Thyroid Cancer"],"prefix":"10.1007","volume":"27","author":[{"given":"Tingting","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taoqi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0267-7819","authenticated-orcid":false,"given":"Fei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"key":"2028_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A (2024) Cancer statistics, 2024. CA Cancer J Clin 74:12\u201349","journal-title":"CA Cancer J Clin"},{"key":"2028_CR2","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3342\/ceo.2015.8.3.289","volume":"8","author":"CH Park","year":"2015","unstructured":"Park CH, Song CM, Ji YB et al (2015) Significance of the extracapsular spread of metastatic lymph nodes in papillary thyroid carcinoma. Clin Exp Otorhinolaryngol 8:289\u2013294","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"2028_CR3","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S2213-8587(21)00027-9","volume":"9","author":"A Miranda-Filho","year":"2021","unstructured":"Miranda-Filho A, Lortet-Tieulent J, Bray F et al (2021) Thyroid cancer incidence trends by histology in 25 countries: a population-based study. Lancet Diabetes Endocrinol 9:225\u2013234","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2028_CR4","doi-asserted-by":"publisher","first-page":"1019037","DOI":"10.3389\/fendo.2022.1019037","volume":"13","author":"SW Lai","year":"2022","unstructured":"Lai SW, Fan YL, Zhu YH et al (2022) Machine learning-based dynamic prediction of lateral lymph node metastasis in patients with papillary thyroid cancer. Front Endocrinol (Lausanne) 13:1019037","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2028_CR5","doi-asserted-by":"publisher","first-page":"109103","DOI":"10.1016\/j.ejrad.2020.109103","volume":"129","author":"Z Xing","year":"2020","unstructured":"Xing Z, Qiu Y, Yang Q et al (2020) Thyroid cancer neck lymph nodes metastasis: Meta-analysis of US and CT diagnosis. Eur J Radiol 129:109103","journal-title":"Eur J Radiol"},{"key":"2028_CR6","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.1007\/s00405-017-4728-z","volume":"274","author":"S Renkonen","year":"2017","unstructured":"Renkonen S, Linden R, Back L et al (2017) Accuracy of preoperative MRI to assess lateral neck metastases in papillary thyroid carcinoma. Eur Arch Otorhinolaryngol 274:3977\u20133983","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"2028_CR7","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.3390\/cancers14122958","volume":"14","author":"L Piscopo","year":"2022","unstructured":"Piscopo L, Nappi C, Volpe F et al (2022) Prognostic value of hybrid PET\/MR imaging in patients with differentiated thyroid cancer. Cancers (Basel) 14:2958","journal-title":"Cancers (Basel)"},{"key":"2028_CR8","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.3390\/cancers13143436","volume":"13","author":"Y Song","year":"2021","unstructured":"Song Y, Liu F, Ruan W et al (2021) Head-to-head comparison of neck (18)F-FDG PET\/MR and PET\/CT in the diagnosis of differentiated thyroid carcinoma patients after comprehensive treatment. Cancers (Basel) 13:3436","journal-title":"Cancers (Basel)"},{"key":"2028_CR9","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1007\/s00259-020-04938-0","volume":"47","author":"M Klain","year":"2020","unstructured":"Klain M, Nappi C, Nicolai E et al (2020) Comparison of simultaneous (18)F-2-[18F] FDG PET\/MR and PET\/CT in the follow-up of patients with differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 47:3066\u20133073","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2028_CR10","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s00259-015-3195-2","volume":"43","author":"A Vrachimis","year":"2016","unstructured":"Vrachimis A, Burg MC, Wenning C et al (2016) [(18)F]FDG PET\/CT outperforms [(18)F]FDG PET\/MRI in differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 43:212\u2013220","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2028_CR11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13550-023-01060-8","volume":"13","author":"Y Wang","year":"2023","unstructured":"Wang Y, Liu Y, Geng H, Zhang W (2023) Advancements in theranostic applications: exploring the role of fibroblast activation protein inhibition tracers in enhancing thyroid health assessment. EJNMMI Res 13:109","journal-title":"EJNMMI Res"},{"key":"2028_CR12","doi-asserted-by":"publisher","first-page":"1381863","DOI":"10.3389\/fmed.2024.1381863","volume":"11","author":"A Rizzo","year":"2024","unstructured":"Rizzo A, Albano D, Dondi F et al (2024) Diagnostic yield of FAP-guided positron emission tomography in thyroid cancer: a systematic review. Front Med (Lausanne) 11:1381863","journal-title":"Front Med (Lausanne)"},{"key":"2028_CR13","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1148\/radiol.212430","volume":"304","author":"H Fu","year":"2022","unstructured":"Fu H, Wu J, Huang J et al (2022) (68)Ga fibroblast activation protein inhibitor PET\/CT in the detection of metastatic thyroid cancer: comparison with (18)F-FDG PET\/CT. Radiology 304:397\u2013405","journal-title":"Radiology"},{"key":"2028_CR14","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s00259-022-06067-2","volume":"50","author":"X Mu","year":"2023","unstructured":"Mu X, Huang X, Jiang Z et al (2023) [(18)F]FAPI-42 PET\/CT in differentiated thyroid cancer: diagnostic performance, uptake values, and comparison with 2-[(18)F]FDG PET\/CT. Eur J Nucl Med Mol Imaging 50:1205\u20131215","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2028_CR15","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1007\/s12149-022-01742-8","volume":"36","author":"Y Chen","year":"2022","unstructured":"Chen Y, Zheng S, Zhang J, Yao S, Miao W (2022) (68)Ga-DOTA-FAPI-04 PET\/CT imaging in radioiodine-refractory differentiated thyroid cancer (RR-DTC) patients. Ann Nucl Med 36:610\u2013622","journal-title":"Ann Nucl Med"},{"key":"2028_CR16","doi-asserted-by":"publisher","first-page":"41416","DOI":"10.1038\/srep41416","volume":"7","author":"A Parascandolo","year":"2017","unstructured":"Parascandolo A, Rappa F, Cappello F et al (2017) Extracellular superoxide dismutase expression in papillary thyroid cancer mesenchymal stem\/stromal cells modulates cancer cell growth and migration. Sci Rep 7:41416","journal-title":"Sci Rep"},{"key":"2028_CR17","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.1007\/s00405-017-4728-z","volume":"274","author":"S Renkonen","year":"2017","unstructured":"Renkonen S, Lind\u00e9n R, B\u00e4ck L et al (2017) Accuracy of preoperative MRI to assess lateral neck metastases in papillary thyroid carcinoma. Eur Arch Otorhinolaryngol 274:3977\u20133983","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"2028_CR18","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1007\/s00330-012-2470-x","volume":"22","author":"YL Seo","year":"2012","unstructured":"Seo YL, Yoon DY, Baek S et al (2012) Detection of neck recurrence in patients with differentiated thyroid cancer: comparison of ultrasound, contrast-enhanced CT and (18)F-FDG PET\/CT using surgical pathology as a reference standard: (ultrasound vs. CT vs. (18)F-FDG PET\/CT in recurrent thyroid cancer). Eur Radiol 22:2246\u20132254","journal-title":"Eur Radiol"},{"key":"2028_CR19","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1210\/jc.2007-0444","volume":"92","author":"S Leboulleux","year":"2007","unstructured":"Leboulleux S, Girard E, Rose M et al (2007) Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer. J Clin Endocrinol Metab 92:3590\u20133594","journal-title":"J Clin Endocrinol Metab"},{"key":"2028_CR20","doi-asserted-by":"crossref","unstructured":"Kuna SK, Bracic I, Tesic V, Kuna K, Herceg GH, Dodig D (2006) Ultrasonographic differentiation of benign from malignant neck lymphadenopathy in thyroid cancer. J Ultrasound Med 25:1531\u20131537 quiz 1538\u20131540","DOI":"10.7863\/jum.2006.25.12.1531"},{"key":"2028_CR21","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1118\/1.4945416","volume":"43","author":"AM Grant","year":"2016","unstructured":"Grant AM, Deller TW, Khalighi MM, Maramraju SH, Delso G, Levin CS (2016) NEMA NU 2\u20132012 performance studies for the SiPM-based ToF-PET component of the GE SIGNA PET\/MR system. Med Phys 43:2334","journal-title":"Med Phys"},{"key":"2028_CR22","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00259-015-3288-y","volume":"43","author":"I Binse","year":"2016","unstructured":"Binse I, Poeppel TD, Ruhlmann M et al (2016) Imaging with (124)I in differentiated thyroid carcinoma: is PET\/MRI superior to PET\/CT? Eur J Nucl Med Mol Imaging 43:1011\u20131017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2028_CR23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3174\/ajnr.A4967","volume":"38","author":"CH Suh","year":"2017","unstructured":"Suh CH, Baek JH, Choi YJ, Lee JH (2017) Performance of CT in the preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid cancer: a systematic review and meta-analysis. AJNR Am J Neuroradiol 38:154\u2013161","journal-title":"AJNR Am J Neuroradiol"},{"key":"2028_CR24","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1016\/j.ejrad.2011.04.028","volume":"81","author":"LM Wu","year":"2012","unstructured":"Wu LM, Gu HY, Qu XH et al (2012) The accuracy of ultrasonography in the preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma: A meta-analysis. Eur J Radiol 81:1798\u20131805","journal-title":"Eur J Radiol"},{"key":"2028_CR25","doi-asserted-by":"publisher","first-page":"168","DOI":"10.5114\/ceji.2022.117376","volume":"47","author":"W Lasek","year":"2022","unstructured":"Lasek W (2022) Cancer immunoediting hypothesis: history, clinical implications and controversies. Cent Eur J Immunol 47:168\u2013174","journal-title":"Cent Eur J Immunol"},{"key":"2028_CR26","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3390\/biomedicines10030523","volume":"10","author":"L Gilardi","year":"2022","unstructured":"Gilardi L, Air\u00f2 Farulla LS, Demirci E, Clerici I, Omodeo Sal\u00e8 E, Ceci F (2022) Imaging cancer-associated fibroblasts (CAFs) with FAPi PET. Biomedicines 10:523","journal-title":"Biomedicines"},{"key":"2028_CR27","doi-asserted-by":"publisher","first-page":"5744","DOI":"10.3390\/cancers13225744","volume":"13","author":"T Lindner","year":"2021","unstructured":"Lindner T, Giesel FL, Kratochwil C, Serfling SE (2021) Radioligands targeting fibroblast activation protein (FAP). Cancers (Basel) 13:5744","journal-title":"Cancers (Basel)"},{"key":"2028_CR28","doi-asserted-by":"publisher","first-page":"e194003","DOI":"10.1148\/rycan.2019194003","volume":"1","author":"DK Hathi","year":"2019","unstructured":"Hathi DK, Jones EF (2019) (68)Ga FAPI PET\/CT: tracer uptake in 28 different kinds of cancer. Radiol Imaging Cancer 1:e194003","journal-title":"Radiol Imaging Cancer"},{"key":"2028_CR29","doi-asserted-by":"publisher","first-page":"e220749","DOI":"10.1148\/radiol.220749","volume":"306","author":"Y Mori","year":"2023","unstructured":"Mori Y, Dendl K, Cardinale J, Kratochwil C, Giesel FL, Haberkorn U (2023) FAPI PET: fibroblast activation protein inhibitor use in oncologic and nononcologic disease. Radiology 306:e220749","journal-title":"Radiology"},{"key":"2028_CR30","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s00259-024-06930-4","volume":"52","author":"Y Chen","year":"2024","unstructured":"Chen Y, Zheng S, Zang J et al (2024) [(68)Ga]Ga-LNC1007 versus 2-[(18)F]FDG in the evaluation of patients with metastatic differentiated thyroid cancer: a head-to-head comparative study. Eur J Nucl Med Mol Imaging 52:683\u2013692","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2028_CR31","doi-asserted-by":"publisher","first-page":"8197","DOI":"10.1007\/s13277-015-4684-4","volume":"37","author":"WY Sun","year":"2016","unstructured":"Sun WY, Jung WH, Koo JS (2016) Expression of cancer-associated fibroblast-related proteins in thyroid papillary carcinoma. Tumour Biol 37:8197\u20138207","journal-title":"Tumour Biol"},{"key":"2028_CR32","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1136\/jclinpath-2020-207357","volume":"74","author":"J Ham","year":"2021","unstructured":"Ham J, Wang B, Po JW, Singh A, Niles N, Lee CS (2021) Cancer-associated fibroblasts (CAFs) in thyroid papillary carcinoma: molecular networks and interactions. J Clin Pathol 74:759\u2013765","journal-title":"J Clin Pathol"},{"key":"2028_CR33","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1158\/0008-5472.CAN-15-2351","volume":"76","author":"LA Jolly","year":"2016","unstructured":"Jolly LA, Novitskiy S, Owens P et al (2016) Fibroblast-mediated collagen remodeling within the tumor microenvironment facilitates progression of thyroid cancers driven by BrafV600E and Pten loss. Cancer Res 76:1804\u20131813","journal-title":"Cancer Res"},{"key":"2028_CR34","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.7150\/thno.22717","volume":"8","author":"C Shangguan","year":"2018","unstructured":"Shangguan C, Gan G, Zhang J et al (2018) Cancer-associated fibroblasts enhance tumor (18)F-FDG uptake and contribute to the intratumor heterogeneity of PET-CT. Theranostics 8:1376\u20131388","journal-title":"Theranostics"},{"key":"2028_CR35","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.mce.2003.10.059","volume":"213","author":"O Doh\u00e1n","year":"2003","unstructured":"Doh\u00e1n O, Carrasco N (2003) Advances in Na(+)\/I(-) symporter (NIS) research in the thyroid and beyond. Mol Cell Endocrinol 213:59\u201370","journal-title":"Mol Cell Endocrinol"},{"key":"2028_CR36","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/RLU.0000000000002046","volume":"43","author":"PS Duarte","year":"2018","unstructured":"Duarte PS, Marin JFG, de Carvalho JWA, Sapienza MT, Buchpiguel CA (2018) Iodine\/FDG \u201cFlip-Flop\u201d phenomenon inside a large metastatic thyroid cancer lesion better characterized on SPECT\/CT and PET\/CT Studies. Clin Nucl Med 43:436\u2013438","journal-title":"Clin Nucl Med"},{"key":"2028_CR37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12964-020-00586-x","volume":"18","author":"S Heydarzadeh","year":"2020","unstructured":"Heydarzadeh S, Moshtaghie AA, Daneshpoor M, Hedayati M (2020) Regulators of glucose uptake in thyroid cancer cell lines. Cell Commun Signal 18:83","journal-title":"Cell Commun Signal"},{"key":"2028_CR38","doi-asserted-by":"publisher","first-page":"R203","DOI":"10.1530\/ERC-13-0088","volume":"20","author":"K Pak","year":"2013","unstructured":"Pak K, Kim SJ, Kim IJ, Kim BH, Kim SS, Jeon YK (2013) The role of 18F-fluorodeoxyglucose positron emission tomography in differentiated thyroid cancer before surgery. Endocr Relat Cancer 20:R203-213","journal-title":"Endocr Relat Cancer"},{"key":"2028_CR39","doi-asserted-by":"crossref","unstructured":"Luster M, Aktolun C, Amendoeira I, et al. (2019) European perspective on 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: Proceedings of an interactive international symposium. Thyroid 29:7\u201326","DOI":"10.1089\/thy.2017.0129"},{"key":"2028_CR40","doi-asserted-by":"publisher","first-page":"e185408","DOI":"10.1172\/JCI185408","volume":"135","author":"H Chen","year":"2024","unstructured":"Chen H, Zhao L, Pang Y et al (2024) 68Ga-MY6349 PET\/CT imaging to assess Trop2 expression in multiple types of cancer. J Clin Invest 135:e185408","journal-title":"J Clin Invest"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-025-02028-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11307-025-02028-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-025-02028-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T22:11:07Z","timestamp":1757196667000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11307-025-02028-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["2028"],"URL":"https:\/\/doi.org\/10.1007\/s11307-025-02028-x","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,24]]},"assertion":[{"value":"18 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The study received ethical approval from the independent ethics committee of Xijng Hospital (Approval No. KY20212145-F-1).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}